- |||||||||| Enrollment closed, Trial primary completion date: Prader-Willi Syndrome Macronutrient Study (clinicaltrials.gov) - Jan 25, 2016
P=N/A, N=10, Active, not recruiting, Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Apr 2016
- |||||||||| Victoza (liraglutide) / Novo Nordisk
Trial termination: Liraglutide Use in Prader-Willi Syndrome (clinicaltrials.gov) - Dec 10, 2015 P4, N=1, Terminated, Not yet recruiting --> Recruiting Active, not recruiting --> Terminated; Subject withdrew
- |||||||||| Enrollment open, Trial initiation date, Trial primary completion date: Fertility Assessment in Patients With Klinefelter Syndrome (clinicaltrials.gov) - Dec 5, 2015
P=N/A, N=60, Recruiting, Active, not recruiting --> Terminated; Subject withdrew Not yet recruiting --> Recruiting | Initiation date: Jul 2015 --> Nov 2015 | Trial primary completion date: Jun 2020 --> Oct 2020
- |||||||||| oxytocin / Generic mfg.
Trial completion: Oxytocin Trial in Prader-Willi Syndrome (clinicaltrials.gov) - Sep 18, 2015 P1, N=24, Completed, Trial primary completion date: Feb 2015 --> Feb 2016 Recruiting --> Completed
- |||||||||| trofinetide (NNZ-2566) / Neuren, Acadia Pharma
Enrollment closed, Enrollment change: A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome (clinicaltrials.gov) - Aug 17, 2015 P2, N=72, Active, not recruiting, Active, not recruiting --> Completed Recruiting --> Active, not recruiting | N=60 --> 72
- |||||||||| sertraline / Generic mfg.
Enrollment closed, Phase classification, Enrollment change, Trial primary completion date: Trial of Sertraline to Treat Children With Fragile X Syndrome (clinicaltrials.gov) - Aug 15, 2015 P2, N=57, Active, not recruiting, Recruiting --> Active, not recruiting | N=60 --> 72 Recruiting --> Active, not recruiting | Phase classification: PN/A --> P2 | N=72 --> 57 | Trial primary completion date: Jul 2014 --> Aug 2015
- |||||||||| Trial completion, Enrollment change, CAR T-Cell Therapy: CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant (clinicaltrials.gov) - Aug 12, 2015
P1/2, N=1, Completed, N=2000 --> 370 | Recruiting --> Terminated | Trial primary completion date: Apr 2017 --> Jun 2015; The technique has been approved and validated Active, not recruiting --> Completed | N=30 --> 1
- |||||||||| Trial completion: Cognitive Remediation in 22q11DS (clinicaltrials.gov) - Aug 12, 2015
P=N/A, N=38, Completed, Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| Enrollment closed, Trial primary completion date: Prenatal Screening for Down Syndrome With DNAFirst (clinicaltrials.gov) - Jul 17, 2015
P=N/A, N=100, Active, not recruiting, Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Jul 2015
- |||||||||| Enrollment closed, Trial primary completion date: X-chromosome Inactivation, Epigenetics and the Transcriptome (clinicaltrials.gov) - Jun 29, 2015
P=N/A, N=395, Active, not recruiting, Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2015 --> Oct 2015
|